Integra LifeSciences Holdings Corporation (IART) Earnings History
Profitable31 years of earnings data (1995–2025) · Positive TTM net income
Loading earnings history...
Integra LifeSciences Holdings Corporation (IART) Earnings Overview
As of November 18, 2026, Integra LifeSciences Holdings Corporation (IART) reported trailing twelve-month net income of $13M, reflecting -7361.2% year-over-year growth. The company earned $0.17 per diluted share over the past four quarters, with a net profit margin of -31.6%.
Looking at the long-term picture, IART's historical earnings data spans multiple years. The company achieved its highest annual net income of $181M in fiscal 2022.
Integra LifeSciences Holdings Corporation maintains positive profitability with a gross margin of 51.7%, operating margin of 4.2%, and net margin of -31.6%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including NVCR (-$122M net income, -20.8% margin), ATRC ($15M net income, -2.1% margin), NTRA (-$165M net income, -9.0% margin), IART has room to improve margins relative to the peer group. Compare IART vs NVCR →
IART Earnings vs Peers
Earnings metrics vs comparable public companies
IART Historical Earnings Data (1995–2025)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$516M | -7337.7% | $68M | $-6.73 | -31.6% | 4.2% |
| 2024 | -$7M | -110.3% | $28M | $-0.09 | -0.4% | 1.8% |
| 2023 | $68M | -62.5% | $112M | $0.84 | 4.4% | 7.2% |
| 2022 | $181M | +6.8% | $239M | $2.16 | 11.6% | 15.3% |
| 2021 | $169M | +26.3% | $197M | $1.98 | 11.0% | 12.8% |
| 2020 | $134M | +166.7% | $151M | $1.57 | 9.8% | 11.0% |
| 2019 | $50M | -17.4% | $94M | $0.58 | 3.3% | 6.2% |
| 2018 | $61M | -6.1% | $111M | $0.72 | 4.1% | 7.5% |
| 2017 | $65M | -13.2% | $45M | $0.82 | 5.4% | 3.8% |
| 2016 | $75M | +2218.9% | $115M | $0.94 | 7.5% | 11.6% |
| 2015 | -$4M | -110.3% | $80M | $-0.05 | -0.4% | 9.0% |
| 2014 | $34M | +300.3% | $66M | $0.52 | 3.7% | 7.1% |
| 2013 | -$17M | -141.2% | -$4M | $-0.29 | -2.0% | -0.4% |
| 2012 | $41M | +47.2% | $74M | $0.72 | 5.0% | 8.9% |
| 2011 | $28M | -57.4% | $55M | $0.48 | 3.6% | 7.0% |
| 2010 | $66M | +28.9% | $99M | $1.09 | 9.0% | 13.5% |
| 2009 | $51M | +45.9% | $98M | $0.87 | 7.5% | 14.3% |
| 2008 | $35M | +4.4% | $47M | $0.48 | 5.3% | 7.2% |
| 2007 | $33M | +13.8% | $67M | $0.56 | 6.1% | 12.2% |
| 2006 | $29M | -20.9% | $59M | $0.49 | 7.0% | 14.0% |
| 2005 | $37M | +116.3% | $56M | $0.57 | 13.4% | 20.2% |
| 2004 | $17M | -36.0% | $25M | $0.28 | 7.5% | 10.8% |
| 2003 | $27M | -23.9% | $40M | $0.43 | 14.5% | 21.4% |
| 2002 | $35M | +34.8% | $19M | $0.57 | 31.3% | 17.0% |
| 2001 | $26M | +329.0% | $14M | $0.47 | 28.0% | 15.3% |
| 2000 | -$11M | -90.4% | -$18M | $-0.33 | -17.6% | -28.3% |
| 1999 | -$6M | +51.2% | -$12M | $-0.18 | -14.1% | -29.2% |
| 1998 | -$12M | +27.6% | -$14M | $-0.38 | -70.3% | -80.6% |
| 1997 | -$17M | -126.7% | -$19M | $-0.58 | -115.6% | -129.3% |
| 1996 | -$8M | +70.5% | -$10M | $-0.27 | -57.3% | -72.5% |
| 1995 | -$25M | - | -$6M | $-1.21 | -249.0% | -58.8% |
Download Data
Export IART earnings history in CSV or JSON format
Free sign-in required to download data
IART Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
31+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
IART — Frequently Asked Questions
Quick answers to the most common questions about buying IART stock.
What is IART earnings per share (EPS)?
IART trailing twelve-month (TTM) diluted EPS is $0.17, reflecting -7361.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1995 to 2025 is available in the table on this page.
What is Integra LifeSciences Holdings Corporation's net income?
Integra LifeSciences Holdings Corporation (IART) trailing twelve-month net income is $13M as of 2025. Earnings declined -7361.2% year-over-year.
Is IART profitable?
Yes, IART is profitable with a TTM net income of $13M and a net profit margin of -31.6%.
What is IART's earnings growth rate?
IART compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1995 to 2025.
What are IART's profit margins?
Integra LifeSciences Holdings Corporation net profit margin is -31.6%, operating margin is +4.2%, and gross margin is +51.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -39.9%.
Is IART growing earnings?
IART earnings are declining — EPS fell -7361.2% year-over-year. TTM net income dropped to $13M. This contrasts with the 5-year CAGR of N/A.
What was IART's best earnings year?
Integra LifeSciences Holdings Corporation's highest annual net income on record is $181M, achieved in fiscal year 2022. Earnings history on this page spans 1995 to 2025 and includes all annual and quarterly figures.
What were IART's earnings last quarter?
IART's most recent reported quarter was Q3 2026. Net income was $15M with diluted EPS of $0.19. For a full breakdown of all quarters, see the quarterly earnings table on this page.